)
Devangshu Datta, an internationally rated chess and bridge player, is a seasoned writer and columnist with extensive experience covering diverse topics such as finance, technology, science, and sports. Known for his analytical approach and clear writing style, Datta has contributed to several leading publications, including Business Standard, The Economic Times, The Telegraph, and Outlook. He also serves on the editorial board of Business Standard.
Devangshu Datta, an internationally rated chess and bridge player, is a seasoned writer and columnist with extensive experience covering diverse topics such as finance, technology, science, and sports. Known for his analytical approach and clear writing style, Datta has contributed to several leading publications, including Business Standard, The Economic Times, The Telegraph, and Outlook. He also serves on the editorial board of Business Standard.
Majority of analysts positive on the stock; their average target price indicates an upside potential of 15 per cent
Improving power demand, new capacity additions, high visibility over coal supply and electricity pricing, and attractive dividend yield augur well
Despite high valuations, analysts are bullish and upgrading targets on the back of volume and margin gains for companies
Neuralink's brain implant devices could cure paralysis and schizophrenia in humans, but concerns about privacy linger
Auto major seen gaining market after higher margins and volumes; valuations though may limit near-term upside
After gaining 40% already in FY24, the stock is trading at a PE of over 100x
Big technical problems need to be solved before nuclear fusion, fuels cells at scale, and quantum computing under normal conditions, get off the ground
Most of the majors have good balance sheets with low debt-to-Ebitda ratios
Notwithstanding the slowdown in IT hiring and rich valuation, most analysts remain positive
Bhabha was born into a wealthy Parsi family (he was related to the Tatas). He studied physics at Cambridge and wrote several well-regarded papers
Investors may use any OFS-led decline in stock price to accumulate its shares
Management has guided for higher output; analysts' average target price is Rs 190, an upside of 20%
Most analysts are positive on the stock with target prices between Rs. 1,250 and Rs. 1,630
In Q4, unit volume declined 14.6 per cent year-on-year
Analysts see an upside of over 24% in insurer's stock in one year
Two stocks are up 14-21% in the last month; Amber has more upside given the target prices
Attractive valuations and robust cash flows are the other positives
Stock plunges 8.35%; analysts divided over electrical equipment maker's prospects due to high valuations
There is a general principle that fiscal policies should be transparent and have obvious motives
Continuing high raw material inflation is a key concern and rupee depreciation continues to be a pain point